Acute myocardial infarction during late COVID-19 era: patient characteristics, presentation and outcomes

Catarina Amaral Marques1, André Cabrita2, Paulo Araújo3

  • 1Department of Cardiology, Centro Hospitalar Universitário São João, Porto. catarinamarques5@hotmail.com.

Insights

Late pandemic acute myocardial infarction (AMI) patients had worse outcomes despite similar care. These patients presented with more cardiovascular disease and severe symptoms, suggesting sicker individuals sought care, while milder cases may have delayed seeking help.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • The COVID-19 pandemic has significantly impacted healthcare delivery, including the management of acute myocardial infarction (AMI).
  • The specific effects on patient characteristics, presentation, treatment, and outcomes in the late pandemic period remain unclear.

Purpose of the Study:

  • To evaluate the differences in patient profiles, clinical presentation, and in-hospital outcomes for acute myocardial infarction (AMI) patients during the late COVID-19 pandemic compared to pre-pandemic times.
  • To investigate potential shifts in healthcare-seeking behavior among AMI patients during the pandemic.

Main Methods:

  • A prospective study comparing type-1 AMI patients admitted to a tertiary care hospital.
  • Data collected from 122 patients in 2019 (pre-COVID-19 group) and 196 patients in 2021 (late-COVID-19 group).
  • Information gathered through patient interviews and medical record reviews.

Main Results:

  • No significant differences were observed in age, gender distribution, ST-elevation myocardial infarction (STEMI) proportion, or access to coronariography and revascularization between the groups.
  • Late-pandemic patients exhibited a higher prevalence of pre-existing cardiovascular disease (CVD) (43% vs. 30%), more typical and intense chest pain, increased AMI complications (27% vs. 15%), and worse Killip class (K≥2 in 22% vs. 13%).
  • Despite comparable pre-hospital and hospital care, late-pandemic AMI patients experienced worse in-hospital outcomes.

Conclusions:

  • Patients experiencing acute myocardial infarction (AMI) during the late pandemic presented with a greater burden of pre-existing cardiovascular disease and more severe symptoms.
  • Worse in-hospital outcomes were observed in late-pandemic AMI patients, even with similar treatment access compared to pre-pandemic periods.
  • Findings suggest that during the pandemic, sicker patients with more pronounced AMI symptoms were more likely to seek medical attention, while those with less severe or typical symptoms may have delayed or avoided care.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
18
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
55
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
32
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
20